Zura Bio Limited
ZURA
$1.21
-$0.05-3.97%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 68.93% | 65.18% | 68.81% | 89.76% | 226.58% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 4.37% | -11.89% | -29.80% | -34.17% | 114.34% |
| Operating Income | -4.37% | 11.89% | 29.80% | 34.17% | -114.34% |
| Income Before Tax | -6.12% | 13.47% | 34.43% | 46.34% | -84.05% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -6.12% | 13.47% | 34.43% | 46.34% | -84.05% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -100.00% | -100.00% | -100.00% |
| Net Income | -6.12% | 13.18% | 32.61% | 44.69% | -96.02% |
| EBIT | -4.37% | 11.89% | 29.80% | 34.17% | -114.34% |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | 56.02% | 87.51% | 99.15% | 99.31% | 97.67% |
| Normalized Basic EPS | 52.95% | 79.62% | 98.46% | 98.58% | 96.68% |
| EPS Diluted | 56.02% | 87.51% | 99.15% | 99.31% | 97.67% |
| Normalized Diluted EPS | 52.95% | 79.62% | 98.46% | 98.58% | 96.68% |
| Average Basic Shares Outstanding | 97.66% | 127.76% | 201.02% | 464.14% | 726.24% |
| Average Diluted Shares Outstanding | 97.66% | 127.76% | 201.02% | 458.54% | 711.56% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |